Diarrhoea does not just cause fluid and electrolyte disturbances; fund
amentally it is a failure of net enteric uptake of sodium and water. T
he most lethal effects are dehydration, particularly loss of extracell
ular (ECF) volume, also acidosis and hyperkalaemia. The importance of
sodium in repairing ECF volume, and as the key constituent (alongside
glucose) of oral rehydration solutions (ORS) was emphasised. Misconcep
tions about the causes of hyponatraemia and hypernatraemia were clarif
ied. The importance of bicarbonate precursors was reaffirmed and argum
ents surrounding glycine were discussed. Glucose acts through cotransp
ort with sodium, not as an energy source and the problem of energy def
icit with conventional ORS was examined. Aspects of the composition of
parenteral fluids were also discussed, notably sodium, potassium and
bicarbonate precursors as well as the use of ORS in conjunction with p
arenteral therapy. The opportunity to tailor therapy according to meas
ured changes in plasma composition, especially acidosis, was identifie
d as a major area of clinical progress. Impediments to progress includ
e licensing constraints designed for receptor-active drugs and the ten
dency for funding bodies to favour blue-sky research rather than genui
ne improvements in deliverable health care.